TD Cowen on Viridian Therapeutic (VRDN): 'VRDN is a Top Pick'
Tweet Send to a Friend
TD Cowen analyst Joseph Thome reiterated a Buy rating on Viridian Therapeutic (NASDAQ: VRDN).The analyst comments "VRDN provided a roadmap ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
